The healthcare industry is undergoing a digital transformation, thanks to the advancement of digital health technologies such as artificial intelligence (AI) and machine learning (ML). These technologies have the potential to revolutionize healthcare and accelerate the development of new medical products, including pharmaceuticals and medical devices.
As AI/ML becomes increasingly prevalent in the healthcare industry, regulatory bodies like the US Food and Drug Administration (FDA) are actively updating their policies to keep pace with the changing landscape. In this webinar, we will explore how the FDA regulates these technologies and their use in health-related purposes. We will also discuss recent FDA developments related to AI/ML and how they affect pharmaceutical and medical device research and development activities.
If you’re interested in gaining valuable insights into the FDA’s approach to regulating digital health technologies, join us for this informative webinar. CLE credit is pending approval for this event in several states, including CA, IL, NY, PA, TX, VA, and WA. Additionally, participants from CT, FL, and NJ can receive CLE credit through reciprocity. Don’t miss out on this opportunity to stay informed about the latest developments in this rapidly evolving field.
